182 related articles for article (PubMed ID: 17933469)
21. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
22. Telomeres rather than telomerase a key target for anti-cancer therapy?
Boukamp P; Mirancea N
Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
[TBL] [Abstract][Full Text] [Related]
23. Telomere uncapping and alternative lengthening of telomeres.
Cesare AJ; Reddel RR
Mech Ageing Dev; 2008; 129(1-2):99-108. PubMed ID: 18215414
[TBL] [Abstract][Full Text] [Related]
24. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
[TBL] [Abstract][Full Text] [Related]
25. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.
Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC
Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
27. Telomere length maintenance--an ALTernative mechanism.
Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
[TBL] [Abstract][Full Text] [Related]
28. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
Hackett JA; Greider CW
Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787
[TBL] [Abstract][Full Text] [Related]
29. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
30. Telomere maintenance in sarcomas.
Johnson JE; Broccoli D
Curr Opin Oncol; 2007 Jul; 19(4):377-82. PubMed ID: 17545803
[TBL] [Abstract][Full Text] [Related]
31. Budding yeast with human telomeres: a puzzling structure.
Auriche C; Di Domenico EG; Ascenzioni F
Biochimie; 2008 Jan; 90(1):108-15. PubMed ID: 17954006
[TBL] [Abstract][Full Text] [Related]
32. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
33. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
Grach AA
Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
[TBL] [Abstract][Full Text] [Related]
34. The levels of telomere-binding proteins in human tumours and therapeutic implications.
Cookson JC; Laughton CA
Eur J Cancer; 2009 Mar; 45(4):536-50. PubMed ID: 19114299
[TBL] [Abstract][Full Text] [Related]
35. The evolving role of telomerase inhibitors in the treatment of cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(6):470-2. PubMed ID: 14594517
[TBL] [Abstract][Full Text] [Related]
36. [Mechanisms of alternative lengthening of telomeres].
Grach AA
Tsitol Genet; 2011; 45(2):69-81. PubMed ID: 21574432
[TBL] [Abstract][Full Text] [Related]
37. Cellular senescence, telomere recombination and maintenance.
Yang Q
Cytogenet Genome Res; 2008; 122(3-4):211-8. PubMed ID: 19188689
[TBL] [Abstract][Full Text] [Related]
38. The human CTC1/STN1/TEN1 complex regulates telomere maintenance in ALT cancer cells.
Huang C; Jia P; Chastain M; Shiva O; Chai W
Exp Cell Res; 2017 Jun; 355(2):95-104. PubMed ID: 28366536
[TBL] [Abstract][Full Text] [Related]
39. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
Villa R; Daidone MG; Motta R; Venturini L; De Marco C; Vannelli A; Kusamura S; Baratti D; Deraco M; Costa A; Reddel RR; Zaffaroni N
Clin Cancer Res; 2008 Jul; 14(13):4134-40. PubMed ID: 18593991
[TBL] [Abstract][Full Text] [Related]
40. Telomeres as targets for anticancer therapies.
Folini M; Venturini L; Cimino-Reale G; Zaffaroni N
Expert Opin Ther Targets; 2011 May; 15(5):579-93. PubMed ID: 21288186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
